Welcome to the Peptide Therapeutics FoundationThe Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: ChemPartner, Ferring Research Institute Inc., Novo Nordisk, Medimmune/ Astra Zeneca, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila. To learn more about our corporate sponsors and board members click here. Click here for an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown. |
Stéphane Bolduc – CHU de Québec – Université Laval Research Center Marcello Costa – Flinders University Warren Foster – University of California, San Diego Andrew Horne – University of Edinburgh K. Joseph Hurt – University of Colorado Ursula Kaiser – Brigham and Women’s Hospital, Harvard Medical School Sarah Marshall – Monash University Kathryn Meier – Washington State University Victor Navarro – Brigham and Women’s Hospital, Harvard Medical School Willis Samson – Saint Louis University, School of Medicine John Taylor – Kansas University Medical Center Suraj Unniappan – University of Saskatchewan Henrique Veiga-Fernandes – Champalimaud Foundation Meet the 2016 Recipients
October 25-26, 2018 The 13th Annual Peptide The Salk Institute |
Click here to learn more about The Peptide Therapeutics Foundation or our Annual Peptide Therapeutics Symposium. |
